URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY

Federica Iavarone; Mario Gardi; Chiara Fanali; Antonio Destito; Matteo Vittori; Enrico Sacco; Francesco Pinto; Massimo Castagnola; Sm Recupero; Andrea Volpe; R Inziatari; M Dal Bianco; L De Zorzi; Pf Bassi

URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY

Federica Iavarone, Mario Gardi, Chiara Fanali, Antonio Destito, Matteo Vittori, Enrico Sacco, Francesco Pinto, Massimo Castagnola, Sm Recupero, Andrea Volpe, R Inziatari, M Dal Bianco, L De Zorzi, Pf Bassi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr

Lingua originale	English
pagine (da-a)	233-233
Numero di pagine	1
Rivista	EUROPEAN UROLOGY. SUPPLEMENTS
Volume	10
Stato di pubblicazione	Pubblicato - 2011

Keywords

RENAL

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY'. Insieme formano una fingerprint unica.

Cita questo

Iavarone, Federica ; Gardi, Mario ; Fanali, Chiara ; Destito, Antonio ; Vittori, Matteo ; Sacco, Enrico ; Pinto, Francesco ; Castagnola, Massimo ; Recupero, Sm ; Volpe, Andrea ; Inziatari, R ; Dal Bianco, M ; De Zorzi, L ; Bassi, Pf. / URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY. In: EUROPEAN UROLOGY. SUPPLEMENTS. 2011 ; Vol. 10. pagg. 233-233.

@article{4227c623883b4ed19491a83c83d2a3ed,

title = "URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY",

abstract = "Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr",

keywords = "RENAL, RENAL",

author = "Federica Iavarone and Mario Gardi and Chiara Fanali and Antonio Destito and Matteo Vittori and Enrico Sacco and Francesco Pinto and Massimo Castagnola and Sm Recupero and Andrea Volpe and R Inziatari and {Dal Bianco}, M and {De Zorzi}, L and Pf Bassi",

year = "2011",

language = "English",

volume = "10",

pages = "233--233",

journal = "European Urology, Supplements",

issn = "1569-9056",

publisher = "[S.l.] ; Basel : Karger : Elsevier Science",

}

URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY. / Iavarone, Federica; Gardi, Mario; Fanali, Chiara; Destito, Antonio; Vittori, Matteo; Sacco, Enrico; Pinto, Francesco; Castagnola, Massimo; Recupero, Sm; Volpe, Andrea; Inziatari, R; Dal Bianco, M; De Zorzi, L; Bassi, Pf.

In: EUROPEAN UROLOGY. SUPPLEMENTS, Vol. 10, 2011, pag. 233-233.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY

AU - Iavarone, Federica

AU - Gardi, Mario

AU - Fanali, Chiara

AU - Destito, Antonio

AU - Vittori, Matteo

AU - Sacco, Enrico

AU - Pinto, Francesco

AU - Castagnola, Massimo

AU - Recupero, Sm

AU - Volpe, Andrea

AU - Inziatari, R

AU - Dal Bianco, M

AU - De Zorzi, L

AU - Bassi, Pf

PY - 2011

Y1 - 2011

N2 - Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr

AB - Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr

KW - RENAL

UR - http://hdl.handle.net/10807/3176

M3 - Article

VL - 10

SP - 233

EP - 233

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

ER -